Northern Trust Corp Esperion Therapeutics, Inc. Transaction History

Northern Trust Corp

  • $761 Billion
  • Q3 2025

A detailed history of Northern Trust Corp transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,848,437 shares of ESPR stock, worth $5.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,848,437
Previous 1,784,126 3.6%
Holding current value
$5.36 Million
Previous $1.75 Million 180.21%
% of portfolio
0.0%
Previous 0.0%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$0.98 - $2.84 $63,024 - $182,643
64,311 Added 3.6%
1,848,437 $4.9 Million
Q2 2025

Aug 13, 2025
BUY
$0.73 - $1.41 $178,936 - $345,616
245,118 Added 15.93%
1,784,126 $1.75 Million
Q1 2025

May 13, 2025
SELL
$1.44 - $2.34 $1,549 - $2,517
-1,076 Reduced 0.07%
1,539,008 $2.22 Million
Q4 2024

Feb 14, 2025
BUY
$1.61 - $3.83 $105,715 - $251,485
65,662 Added 4.45%
1,540,084 $3.39 Million
Q3 2024

Nov 13, 2024
BUY
$1.61 - $2.73 $1.72 Million - $2.92 Million
1,069,384 Added 264.02%
1,474,422 $2.43 Million
Q2 2024

Aug 14, 2024
BUY
$1.84 - $3.24 $177,304 - $312,209
96,361 Added 31.22%
405,038 $899,000
Q1 2024

May 14, 2024
BUY
$2.02 - $3.02 $145,609 - $217,693
72,084 Added 30.47%
308,677 $827,000
Q4 2023

Feb 13, 2024
BUY
$0.73 - $3.08 $5,754 - $24,279
7,883 Added 3.45%
236,593 $707,000
Q3 2023

Nov 13, 2023
BUY
$0.96 - $1.79 $64,780 - $120,789
67,480 Added 41.85%
228,710 $224,000
Q2 2023

Aug 11, 2023
SELL
$1.2 - $1.76 $618,110 - $906,561
-515,092 Reduced 76.16%
161,230 $224,000
Q1 2023

May 15, 2023
BUY
$1.46 - $7.3 $16,408 - $82,044
11,239 Added 1.69%
676,322 $1.08 Million
Q4 2022

Feb 13, 2023
BUY
$5.09 - $8.5 $422,851 - $706,137
83,075 Added 14.27%
665,083 $4.14 Million
Q3 2022

Nov 14, 2022
BUY
$5.45 - $8.13 $78,000 - $116,356
14,312 Added 2.52%
582,008 $3.9 Million
Q2 2022

Aug 12, 2022
BUY
$4.77 - $6.67 $199,653 - $279,179
41,856 Added 7.96%
567,696 $3.61 Million
Q1 2022

May 13, 2022
BUY
$3.34 - $5.56 $630,201 - $1.05 Million
188,683 Added 55.96%
525,840 $2.44 Million
Q4 2021

Feb 08, 2022
BUY
$4.81 - $11.92 $203,535 - $504,394
42,315 Added 14.35%
337,157 $1.69 Million
Q3 2021

Nov 15, 2021
SELL
$11.34 - $21.37 $204,641 - $385,643
-18,046 Reduced 5.77%
294,842 $3.55 Million
Q2 2021

Aug 13, 2021
BUY
$19.4 - $28.71 $154,482 - $228,617
7,963 Added 2.61%
312,888 $6.62 Million
Q1 2021

May 12, 2021
SELL
$25.12 - $36.89 $510,413 - $749,567
-20,319 Reduced 6.25%
304,925 $8.55 Million
Q4 2020

Feb 11, 2021
SELL
$24.2 - $35.76 $310,316 - $458,550
-12,823 Reduced 3.79%
325,244 $8.46 Million
Q3 2020

Nov 16, 2020
SELL
$31.18 - $52.71 $456,942 - $772,465
-14,655 Reduced 4.15%
338,067 $12.6 Million
Q2 2020

Aug 14, 2020
BUY
$30.04 - $51.31 $1.17 Million - $1.99 Million
38,789 Added 12.36%
352,722 $18.1 Million
Q1 2020

May 14, 2020
BUY
$27.44 - $73.84 $97,988 - $263,682
3,571 Added 1.15%
313,933 $9.9 Million
Q4 2019

Feb 14, 2020
SELL
$35.4 - $59.82 $271,872 - $459,417
-7,680 Reduced 2.41%
310,362 $18.5 Million
Q3 2019

Nov 13, 2019
BUY
$34.47 - $47.53 $872,780 - $1.2 Million
25,320 Added 8.65%
318,042 $11.7 Million
Q2 2019

Aug 13, 2019
BUY
$40.1 - $52.33 $107,828 - $140,715
2,689 Added 0.93%
292,722 $13.6 Million
Q1 2019

May 13, 2019
BUY
$40.11 - $53.57 $88,482 - $118,175
2,206 Added 0.77%
290,033 $11.6 Million
Q4 2018

Feb 12, 2019
SELL
$36.99 - $59.11 $12.5 Million - $20 Million
-338,812 Reduced 54.07%
287,827 $13.2 Million
Q3 2018

Nov 14, 2018
BUY
$40.74 - $51.41 $1.49 Million - $1.88 Million
36,535 Added 6.19%
626,639 $27.8 Million
Q2 2018

Sep 18, 2018
SELL
$36.2 - $76.4 $58,716 - $123,920
-1,622 Reduced 0.27%
590,104 $23.1 Million
Q2 2018

Aug 14, 2018
BUY
$36.2 - $76.4 $446,128 - $941,553
12,324 Added 2.13%
591,726 $23.2 Million
Q1 2018

May 09, 2018
BUY
$65.94 - $80.76 $331,348 - $405,819
5,025 Added 0.87%
579,402 $41.9 Million
Q4 2017

Feb 14, 2018
SELL
$43.47 - $67.43 $153,883 - $238,702
-3,540 Reduced 0.61%
574,377 $37.8 Million
Q3 2017

Nov 13, 2017
BUY
$43.8 - $52.77 $25.3 Million - $30.5 Million
577,917
577,917 $29 Million

Others Institutions Holding ESPR

# of Institutions
214
Shares Held
114M
Call Options Held
643K
Put Options Held
769K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $193M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email